Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
STAG Industrial
STAG
$7.77B
| $162M | 0.1% |
4,132,914
-323,468
| -7% | -$11.5M |
|
202
Applied Materials
AMAT
$410B
| $161M | 0.1% |
995,841
-62,126
| -6% | -$9.13M |
|
203
Alight
ALIT
$520M
| $160M | 0.1% |
936,459
+4,978
| +0.5% | +$736K |
|
204
Capital One
COF
$127B
| $159M | 0.09% |
1,211,251
-24,046
| -2% | -$2.59M |
|
205
OSI Systems
OSIS
$3.58B
| $159M | 0.09% |
1,230,206
+1,346
| +0.1% | +$160K |
|
206
Marriott International
MAR
$101B
| $158M | 0.09% |
699,885
-3,640
| -0.5% | -$738K |
|
|
AVDL
207
DELISTED
Avadel Pharmaceuticals
AVDL
| $157M | 0.09% |
11,125,330
+487,023
| +5% | +$5.72M |
|
208
Micron Technology
MU
$1.02T
| $155M | 0.09% |
1,819,852
+358,194
| +25% | +$26.6M |
|
209
Ardelyx
ARDX
$1.25B
| $153M | 0.09% |
24,658,820
-2,623,801
| -10% | -$11.8M |
|
210
American Electric Power
AEP
$72.7B
| $149M | 0.09% |
1,829,526
+924,621
| +102% | +$71.8M |
|
|
AXON
211
Axon Enterprise
AXON
$42.4B
| $146M | 0.09% |
566,301
-130,683
| -19% | -$29.4M |
|
|
GTLS
212
DELISTED
Chart Industries
GTLS
| $146M | 0.09% |
1,068,400
+76,066
| +8% | +$10.3M |
|
213
Coca-Cola
KO
$362B
| $145M | 0.09% |
2,462,741
-4,201,190
| -63% | -$239M |
|
|
CBAY
214
DELISTED
Cymabay Therapeutics
CBAY
| $144M | 0.09% |
6,103,797
-699,687
| -10% | -$12.5M |
|
215
Gilead Sciences
GILD
$162B
| $143M | 0.09% |
1,769,900
-118,742
| -6% | -$9.24M |
|
216
Vanguard Total International Stock ETF
VXUS
$153B
| $143M | 0.09% |
2,470,997
-40,938
| -2% | -$2.24M |
|
217
Euronet Worldwide
EEFT
$3.01B
| $140M | 0.08% |
1,375,058
+1,203
| +0.1% | +$103K |
|
218
Welltower
WELL
$175B
| $139M | 0.08% |
1,543,300
+286,891
| +23% | +$24.9M |
|
219
Magnolia Oil & Gas
MGY
$5.69B
| $138M | 0.08% |
6,481,732
-122,532
| -2% | -$2.68M |
|
220
Carlisle Companies
CSL
$13.8B
| $137M | 0.08% |
437,322
-4,744
| -1% | -$1.31M |
|
221
ITT
ITT
$17.7B
| $137M | 0.08% |
1,144,411
-106,327
| -9% | -$11.2M |
|
222
Ryan Specialty Holdings
RYAN
$5.59B
| $134M | 0.08% |
3,103,916
+15,620
| +0.5% | +$704K |
|
|
CCC
223
CCC Intelligent Solutions
CCC
$3.5B
| $132M | 0.08% |
11,612,314
+2,969,450
| +34% | +$34.7M |
|
224
EnerSys
ENS
$6.94B
| $130M | 0.08% |
1,291,974
+7,051
| +0.5% | +$648K |
|
225
Glaukos
GKOS
$8.92B
| $128M | 0.08% |
1,616,534
+1,357
| +0.1% | +$92.5K |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.